AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2020
Dec 2, 2020
30016_dirs_2020-12-02_eb99cbc7-c7f2-445c-9daf-451a31e2c170.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-11-30
Reporting Person: TWIGGE GIOVANI (CORPORATE VICE PRESIDENT)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-30 | Common Stock | M | 12801 | $67.85 | Acquired | 25723 | Direct |
| 2020-11-30 | Common Stock | S | 12801 | $456.4929 | Disposed | 12922 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-30 | Non-Qualified Stock Option (right-to-buy) | $67.85 | M | 12801 | Disposed | 2026-02-13 | Common Stock (12801) | Direct |
Footnotes
F1: Includes 16 shares purchased under the Issuer's Employee Stock Purchase Plan on September 30, 2020.
F2: Represents the weighted average price of the shares sold ranging from a low of $456.00 to a high of $457.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3: Grant of option to buy 22,028 shares of IDEXX Laboratories, Inc. common stock that vests in five annual installments beginning February 14, 2017.
F4: Not applicable.